HER-2 overexpression is a negative predictive factor for recurrence in patients with non-muscle-invasive bladder cancer on intravesical therapy

OBJECTIVE: HER-2 is overexpressed in a variety of human malignant tumors and has been widely used in the prognosis and treatment of breast cancer. In urothelial cell carcinoma of the bladder, some reports have shown an association between HER-2 overexpression and worse outcomes. The aim of this stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Moustakas, Georgios, Kampantais, Spyridon, Nikolaidou, Anastasia, Vakalopoulos, Ioannis, Tzioufa, Valentini, Dimitriadis, Georgios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Retrospective Clinical Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7112244/
https://www.ncbi.nlm.nih.gov/pubmed/31937176
http://dx.doi.org/10.1177/0300060519895847

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7112244/
https://www.ncbi.nlm.nih.gov/pubmed/31937176
http://dx.doi.org/10.1177/0300060519895847

Ejemplares similares